Here, we present the results from a retrospective analysis, with the purpose of evaluating the safety and feasibility of nivolumab and radiotherapy (RT) concomitant association in metastatic kidney and lung cancer patients.
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer / Desideri I.; Francolini G.; Scotti V.; Pezzulla D.; Becherini C.; Terziani F.; Delli Paoli C.; Olmetto E.; Visani L.; Meattini I.; Greto D.; Bonomo P.; Loi M.; Detti B.; Livi L.. - In: CLINICAL & TRANSLATIONAL ONCOLOGY. - ISSN 1699-048X. - STAMPA. - 21:(2019), pp. 933-938. [10.1007/s12094-018-02005-7]
Benefit of ablative versus palliative-only radiotherapy in combination with nivolumab in patients affected by metastatic kidney and lung cancer
Desideri I.;Francolini G.;Scotti V.;Pezzulla D.;Becherini C.;Terziani F.;Delli Paoli C.;Olmetto E.;Visani L.;Meattini I.;Greto D.;Bonomo P.;Loi M.;Livi L.
2019
Abstract
Here, we present the results from a retrospective analysis, with the purpose of evaluating the safety and feasibility of nivolumab and radiotherapy (RT) concomitant association in metastatic kidney and lung cancer patients.
| File | Dimensione | Formato | |
|---|---|---|---|
|
2018_Desideri I_Clinical Transl Oncol.pdf
Accesso chiuso
Descrizione: Paper
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
670.82 kB
Formato
Adobe PDF
|
670.82 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
